67 research outputs found
Decreased pain sensitivity among people with schizophrenia: A meta-analysis of experimental pain induction studies
Patients with schizophrenia report reduced pain sensitivity in clinical studies, but experimental studies are required to establish pain sensitivity as a potential endophenotype. We conducted a systematic review of electronic databases from database inception until April 15, 2015, including experimental studies investigating pain among patients with schizophrenia spectrum disorder vs healthy controls. A random-effect meta-analysis yielding Hedges' g ±95% confidence intervals (CIs) as the effect size (ES) measure was conducted. Primary outcome was a pooled composite of pain threshold and pain tolerance; secondary outcomes included these parameters individually, plus sensory threshold, physiological pain response, and pain intensity or unpleasantness. Across 17 studies, patients with schizophrenia spectrum disorder (n = 387; age, 30.7 ± 6.9 years; females, 31.9%; illness duration, 7.0 ± 5.7 years) were compared with controls (n = 483; age, 29.5 ± 7.4 years; females, 31.0%). Patients had elevated pain threshold/pain tolerance vs controls (ES = 0.583; 95% CI, 0.212-0.954; P = 0.002; studies = 15). Results were similar in antipsychotic-free individuals (ES = 0.599; 95% CI, 0.291-0.907; P < 0.0001; studies = 8), with trend-level significance in antipsychotic-treated individuals (ES = 0.566; 95% CI, -0.007 to 1.125; P = 0.047; studies = 9). Likewise, patients with schizophrenia had increased pain tolerance (ES = 0.566; 95% CI, 0.235-0.897; P = 0.0001; studies = 6), sensory threshold (ES = 1.16; 95% CI, 0.505-1.727; P < 0.0001; studies = 5), and pain threshold (ES = 0.696; 95% CI, 0.407-0.986; P < 0.001; studies = 9), as well as reduced physiological response to noxious stimuli (ES = 0.456; 95% CI, 0.131-0.783; P = 0.006) and pain intensity/unpleasantness ratings (ES = 0.547; 95% CI, 0.146-0.949; P = 0.008). Findings were similarly significant in antipsychotic-free patients with schizophrenia (analysable parameters = 4) and antipsychotic-treated individuals (analysable parameters = 2). Finally, greater psychiatric symptoms moderated increased pain threshold, and younger patient age moderated increased pain tolerance. Decreased pain sensitivity seems to be an endophenotype of schizophrenia spectrum disorders. How this alteration links to other dimensions of schizophrenia and physical comorbidity-related help-seeking behaviour/morbidity/mortality requires further study
Methodological adequacy of articles published in two open-access Brazilian cardiology periodicals
EPIdemiology of Surgery-Associated Acute Kidney Injury (EPIS-AKI) : Study protocol for a multicentre, observational trial
More than 300 million surgical procedures are performed each year. Acute kidney injury (AKI) is a common complication after major surgery and is associated with adverse short-term and long-term outcomes. However, there is a large variation in the incidence of reported AKI rates. The establishment of an accurate epidemiology of surgery-associated AKI is important for healthcare policy, quality initiatives, clinical trials, as well as for improving guidelines. The objective of the Epidemiology of Surgery-associated Acute Kidney Injury (EPIS-AKI) trial is to prospectively evaluate the epidemiology of AKI after major surgery using the latest Kidney Disease: Improving Global Outcomes (KDIGO) consensus definition of AKI. EPIS-AKI is an international prospective, observational, multicentre cohort study including 10 000 patients undergoing major surgery who are subsequently admitted to the ICU or a similar high dependency unit. The primary endpoint is the incidence of AKI within 72 hours after surgery according to the KDIGO criteria. Secondary endpoints include use of renal replacement therapy (RRT), mortality during ICU and hospital stay, length of ICU and hospital stay and major adverse kidney events (combined endpoint consisting of persistent renal dysfunction, RRT and mortality) at day 90. Further, we will evaluate preoperative and intraoperative risk factors affecting the incidence of postoperative AKI. In an add-on analysis, we will assess urinary biomarkers for early detection of AKI. EPIS-AKI has been approved by the leading Ethics Committee of the Medical Council North Rhine-Westphalia, of the Westphalian Wilhelms-University MĂŒnster and the corresponding Ethics Committee at each participating site. Results will be disseminated widely and published in peer-reviewed journals, presented at conferences and used to design further AKI-related trials. Trial registration number NCT04165369
Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
The complement system has moved into the focus of drug development efforts in the last decade, since its inappropriate or uncontrolled activation has been recognized in many diseases. Some of them are primarily complement-mediated rare diseases, such as paroxysmal nocturnal hemoglobinuria, C3 glomerulonephritis, and atypical hemolytic uremic syndrome. Complement also plays a role in various multifactorial diseases that affect millions of people worldwide, such as ischemia reperfusion injury (myocardial infarction, stroke), age-related macular degeneration, and several neurodegenerative disorders. In this review, we summarize the potential advantages of targeting various complement proteins with special emphasis on the components of the lectin (LP) and the alternative pathways (AP). The serine proteases (MASP-1/2/3, factor D, factor B), which are responsible for the activation of the cascade, are straightforward targets of inhibition, but the pattern recognition molecules (mannose-binding lectin, other collectins, and ficolins), the regulatory components (factor H, factor I, properdin), and C3 are also subjects of drug development. Recent discoveries about cross-talks between the LP and AP offer new approaches for clinical intervention. Mannan-binding lectin-associated serine proteases (MASPs) are not just responsible for LP activation, but they are also indispensable for efficient AP activation. Activated MASP-3 has recently been shown to be the enzyme that continuously supplies factor D (FD) for the AP by cleaving pro-factor D (pro-FD). In this aspect, MASP-3 emerges as a novel feasible target for the regulation of AP activity. MASP-1 was shown to be required for AP activity on various surfaces, first of all on LPS of Gram-negative bacteria
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus
Background: Chronic obstructive pulmonary disease (COPD) has been classically divided into blue bloaters and pink puffers. The utility of these clinical subtypes is unclear. However, the broader distinction between airway-predominant and emphysema-predominant COPD may be clinically relevant. The objective was to define clinical features of emphysema-predominant and non-emphysematous COPD patients. Methods: Current and former smokers from the Genetic Epidemiology of COPD Study (COPDGene) had chest computed tomography (CT) scans with quantitative image analysis. Emphysema-predominant COPD was defined by low attenuation area at -950 Hounsfield Units (LAA-950) â„10%. Non-emphysematous COPD was defined by airflow obstruction with minimal to no emphysema (LAA-950 < 5%). Results: Out of 4197 COPD subjects, 1687 were classified as emphysema-predominant and 1817 as non-emphysematous; 693 had LAA-950 between 5-10% and were not categorized. Subjects with emphysema-predominant COPD were older (65.6 vs 60.6 years, p < 0.0001) with more severe COPD based on airflow obstruction (FEV1 44.5 vs 68.4%, p < 0.0001), greater exercise limitation (6-minute walk distance 1138 vs 1331 ft, p < 0.0001) and reduced quality of life (St. George's Respiratory Questionnaire score 43 vs 31, p < 0.0001). Self-reported diabetes was more frequent in non-emphysematous COPD (OR 2.13, p < 0.001), which was also confirmed using a strict definition of diabetes based on medication use. The association between diabetes and non-emphysematous COPD was replicated in the ECLIPSE study. Conclusions: Non-emphysematous COPD, defined by airflow obstruction with a paucity of emphysema on chest CT scan, is associated with an increased risk of diabetes. COPD patients without emphysema may warrant closer monitoring for diabetes, hypertension, and hyperlipidemia and vice versa
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.
CONTEXT: 4H or POLR3-related leukodystrophy is an autosomal recessive disorder typically characterized by hypomyelination, hypodontia, and hypogonadotropic hypogonadism, caused by biallelic pathogenic variants in POLR3A, POLR3B, POLR1C, and POLR3K. The endocrine and growth abnormalities associated with this disorder have not been thoroughly investigated to date. OBJECTIVE: To systematically characterize endocrine abnormalities of patients with 4H leukodystrophy. DESIGN: An international cross-sectional study was performed on 150 patients with genetically confirmed 4H leukodystrophy between 2015 and 2016. Endocrine and growth abnormalities were evaluated, and neurological and other non-neurological features were reviewed. Potential genotype/phenotype associations were also investigated. SETTING: This was a multicenter retrospective study using information collected from 3 predominant centers. PATIENTS: A total of 150 patients with 4H leukodystrophy and pathogenic variants in POLR3A, POLR3B, or POLR1C were included. MAIN OUTCOME MEASURES: Variables used to evaluate endocrine and growth abnormalities included pubertal history, hormone levels (estradiol, testosterone, stimulated LH and FSH, stimulated GH, IGF-I, prolactin, ACTH, cortisol, TSH, and T4), and height and head circumference charts. RESULTS: The most common endocrine abnormalities were delayed puberty (57/74; 77% overall, 64% in males, 89% in females) and short stature (57/93; 61%), when evaluated according to physician assessment. Abnormal thyroid function was reported in 22% (13/59) of patients. CONCLUSIONS: Our results confirm pubertal abnormalities and short stature are the most common endocrine features seen in 4H leukodystrophy. However, we noted that endocrine abnormalities are typically underinvestigated in this patient population. A prospective study is required to formulate evidence-based recommendations for management of the endocrine manifestations of this disorder
Efektivitas Metode Pembelajaran Resitasi (Recitation Method) dalam Meningkatkan Hasil Belajar Ilmu Pengetahuan Alam Materi Pokok Energi dan Perubahannya Kelas IV MI Masalikil Huda I Kecamatan Tahunan Kabupaten Jepara
Metode resitasi (Recitation Method) merupakan salah satu alternatif metode pembelajaran yang digunakan untuk meningkatkan hasil belajar IPA. Penggunaan metode pembelajaran di MI Masalikil Huda 1 Tahunan Jepara dilatar belakangi oleh rendahnya hasil belajar IPA yang dicapai peserta didik. Dengan menggunakan metode pembelajaran ini peserta didik dapat belajar bersama, saling membantu, mengintegrasikan pengetahuan baru dengan pengetahuan yang telah mereka miliki, menemukan pemahamannya sendiri lewat eksplorasi dalam diskusi, saling merevisi, menjelaskan dan mempertanyakan gagasan-gagasan yang muncul dalam kelompoknya.
Penelitian ini merupakan jenis penelitian kuantitatif dengan metode penelitian eksperimen yang berdesain âpost test control group designâ. Tujuan penelitian ini adalah untuk mengetahui efektivitas metode pembelajaran resitasi (recitation method) dalam meningkatkan hasil belajar ilmu pengetahuan alam materi pokok energi dan perubahannya kelas IV Mi Masalikil Huda I Kecamatan Tahunan Kabupaten Jepara.
Penelitian yang dilakukan adalah penelitian populasi yaitu berupa keseluruhan subjek yang ada dalam penelitian. Adapun populasi dalam penelitian ini adalah kelas IV A dan IV B MI Masalikil Huda 1 Tahunan Jepara tahun pelajaran 2011/2012. Karena penelitian ini merupakan penelitian populasi sehingga semua kelas menjadi sampel. Sampel penelitian ini ada 2 kelas yaitu kelas IV A dan IV B. yang kemudian setelah dilakukan uji normalitas dan homogenitas pada kedua kelas tersebut yang terpilih menjadi kelompok pertama sebagai kelas eksperimen yaitu kelas IV A dan kelompok kedua sebagai kelas kontrol yaitu kelas IV B. Pada akhir pembelajaran kedua kelas diberi tes dengan menggunakan instrumen yang sama yang telah diuji validitas, tingkat kesukaran, daya pembeda, dan reliabilitasnya. Metode pengumpulan data pada penelitian ini adalah metode dokumentasi dan metode tes.
Setelah data dianalisis, diperoleh hasil sebagai berikut: kelompok eksperimen dan kontrol memiliki rata-rata hasil belajar berturut-turut adalah
= 4,542 dikonsultasikan dengan pada α = 5 % = 56 diperoleh
= 1,67. Oleh karena > , maka Ho ditolak. Hal ini menunjukkan bahwa hasil pembelajaran yang menggunakan metode resitasi dengan hasil pembelajaran yang menggunakan pembelajaran konvensional berbeda secara nyata.
Berdasarkan hasil penelitian dan pembahasan dapat disimpulkan bahwa rata-rata hasil tes kelas eksperimen lebih besar daripada kelas kontrol sehingga dapat dikatakan metode resitasi efektif terhadap hasil belajar peserta didik pada materi pokok IPA peserta didik kelas IV MI Masalikil Huda 1 kecamatan Tahunan Kabupaten Jepara, dan disarankan guru dapat terus mengembangkan metode resitasi dan menerapkan pada pembelajaran materi pokok yang lainnya
Vitamin D supplements improve urticaria symptoms and quality of life in chronic spontaneous urticaria patients: A prospective case-control study
Seismic Vulnerability of Low- and Mid-Rise Reinforced Concrete Buildings in Malaysia Designed by Considering Only Gravity Loads
- âŠ